214370.KQ
Caregen Co., Ltd.
KOE · Basic Materials · Chemicals · KR
KRW 43,850.00
−7.29%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 74.9B | 72.8B | 82.6B | 79.2B | 69.1B |
| Cost of Revenue | 22.7B | 20.6B | 27.3B | 20.8B | 16.8B |
| Gross Profit | 52.2B | 52.2B | 55.3B | 58.4B | 52.3B |
| Operating Expenses | |||||
| R&D Expense | 4.9B | 5.8B | 7.0B | 5.8B | 6.3B |
| SG&A Expense | 21.4B | 4.9B | 5.3B | 4.2B | 4.3B |
| General & Admin Expense | 517.4M | 711.2M | 899.8M | 736.5M | 818.6M |
| Selling & Marketing Expense | 3.6B | 4.2B | 4.4B | 3.5B | 3.5B |
| Other Expenses | 18.2B | 21.2B | 8.7B | 6.1B | 8.1B |
| Total Operating Expenses | 28.3B | 31.8B | 21.1B | 16.1B | 18.7B |
| Cost and Expenses | 51.6B | 52.4B | 48.3B | 37.0B | 35.5B |
| Operating Income (EBIT) | 23.3B | 20.4B | 34.2B | 42.2B | 33.6B |
| Non-Operating | |||||
| Interest Income | 2.1B | 4.5B | 977.7M | 3.6B | 596.4M |
| Interest Expense | — | 2.8B | — | 1.0K | — |
| Net Interest Income | 2.1B | 1.6B | 977.7M | 3.6B | 596.4M |
| Other Non-Op Income/Expense | 8.4B | 2.0B | 5.9B | 7.4B | 831.1M |
| Non-Operating Income (excl Interest) | — | — | — | 1.8B | (620.00) |
| EBT (Pre-Tax Income) | 31.7B | 22.4B | 40.2B | 49.6B | 34.5B |
| Income Tax Expense | 4.8B | 2.3B | 7.9B | 9.6B | 7.2B |
| Bottom Line | |||||
| Net Income | 26.9B | 20.1B | 32.3B | 39.9B | 27.3B |
| Earnings from Cont. Ops | 26.9B | 20.1B | 32.3B | 39.9B | 27.2B |
| Earnings from Discont. Ops | — | — | — | — | 2.0K |
| Bottom Line Net Income | 26.9B | 20.1B | 32.3B | 39.9B | 27.3B |
| Per Share | |||||
| Basic EPS | ₩549 | ₩411 | ₩657 | ₩813 | ₩556 |
| Diluted EPS | ₩549 | ₩411 | ₩657 | ₩813 | ₩556 |
| Revenue Per Share | ₩1,533 | ₩1,488 | ₩1,680 | ₩1,613 | ₩1,408 |
| Shares | |||||
| Basic Shares Outstanding | 48.9M | 48.9M | 49.1M | 49.1M | 49.1M |
| Diluted Shares Outstanding | 48.9M | 48.9M | 49.1M | 49.1M | 49.1M |
| Profitability Metrics | |||||
| EBITDA | 27.0B | 25.4B | 39.4B | 45.4B | 37.1B |
| D&A | 5.0B | 5.0B | 5.2B | 5.0B | 3.5B |
| EBIT | 23.3B | 20.4B | 34.2B | 40.4B | 33.6B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026